The first batches of a cutting-edge new vaccine against cervical cancer have arrived in the UK, but for the time being are only available in private clinics.
Gardasil provides protection against the most common types of human papilloma virus which causes cancer and is most useful in girls who have yet to partake in sexual activity.
Many are forecasting a nationwide immunisation programme by the Department of Health for females aged nine to 15.
Such a campaign could cost the NHS approximately £90 million a year.
Professor Margaret Stanley, of the University of Cambridge, said: "It really is a remarkable development that will save lives and cut the number of smear tests a woman has in her lifetime.
"If you are going to prevent a viral infection what do you do? You vaccinate.The vaccines are the most important development in the prevention of cervical cancer since cervical cancer screening programmes began."
The Department of Health has stated that it is "aware" of Gardasil and was taking advice from the Joint Committee on Vaccination regarding its efficacy.
Gardasil is manufactured by pharmaceuticals giant Merck and was given regulatory approval in Europe last month.
Every year 230,000 women die from cervical cancer.
© Adfero Ltd